🇺🇸 ACEI in United States

FDA authorised ACEI on 25 June 1991

Marketing authorisations

FDA — authorised 25 June 1991

  • Application: NDA019851
  • Marketing authorisation holder: VALIDUS PHARMS
  • Local brand name: LOTENSIN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

ACEI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in United States

Frequently asked questions

Is ACEI approved in United States?

Yes. FDA authorised it on 25 June 1991; FDA has authorised it.

Who is the marketing authorisation holder for ACEI in United States?

VALIDUS PHARMS holds the US marketing authorisation.